Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126366241 | 12636624 | 1 | I | 20160721 | 20160804 | 20160809 | 20160809 | EXP | US-PFIZER INC-2016376062 | PFIZER | 0.00 | F | Y | 0.00000 | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126366241 | 12636624 | 1 | PS | PREMPRO | ESTROGENS, CONJUGATEDMEDROXYPROGESTERONE ACETATE | 1 | Oral | 1 DF, 1X/DAY (CONJUGATED ESTROGENS-0.625MG/ MEDROXYPROGESTERONE ACETATE-2.5MG, ORALLY, 1 PILL A DAY) | Y | HO39913 | 20527 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126366241 | 12636624 | 1 | Hot flush |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126366241 | 12636624 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126366241 | 12636624 | Constipation | |
| 126366241 | 12636624 | Dizziness | |
| 126366241 | 12636624 | Micturition disorder | |
| 126366241 | 12636624 | Nausea | |
| 126366241 | 12636624 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126366241 | 12636624 | 1 | 20160720 | 201607 | 0 |